The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Adma Biologics Inc’s stock clocked out at $21.83, up 0.05% from its previous closing price of $21.82. In other words, the price has increased by $0.05 from its previous closing price. On the day, 1.94 million shares were traded. ADMA stock price reached its highest trading level at $22.1899 during the session, while it also had its lowest trading level at $21.53.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 65.03. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 5160393728 and an Enterprise Value of 5185076224. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 79.01, and their Forward P/E ratio for the next fiscal year is 30.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.49 while its Price-to-Book (P/B) ratio in mrq is 22.25. Its current Enterprise Value per Revenue stands at 13.545 whereas that against EBITDA is 41.186.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is 14.69%, while the 200-Day Moving Average is calculated to be 74.63%.
Shares Statistics:
It appears that ADMA traded 5.08M shares on average per day over the past three months and 2612950 shares per day over the past ten days. A total of 236.39M shares are outstanding, with a floating share count of 228.45M. Insiders hold about 3.36% of the company’s shares, while institutions hold 88.31% stake in the company. Shares short for ADMA as of 1731628800 were 14239500 with a Short Ratio of 2.80, compared to 1728950400 on 16073315. Therefore, it implies a Short% of Shares Outstanding of 14239500 and a Short% of Float of 6.2.
